Dataset Information


A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation.

ABSTRACT: T lymphocytes exhibit pro-inflammatory or anti-inflammatory activities in obesity and diabetes, depending on their subtypes. Guanidine-rich immunosuppressive oligodeoxynucleotides (ODNs) effectively control Th1/Th2-cell counterbalance. This study reveals a non-toxic regulatory ODN (ODNR01) that inhibits Th1- and Th17-cell polarization by binding to STAT1/3/4 and blocking their phosphorylation without affecting Th2 and regulatory T cells. ODNR01 improves glucose tolerance and insulin sensitivity in both diet-induced obese (DIO) and genetically generated obese (ob/ob) mice. Mechanistic studies show that ODNR01 suppresses Th1- and Th17-cell differentiation in white adipose tissue, thereby reducing macrophage accumulation and M1 macrophage inflammatory molecule expression without affecting M2 macrophages. While ODNR01 shows no effect on diabetes in lymphocyte-free Rag1-deficient DIO mice, it enhances glucose tolerance and insulin sensitivity in CD4(+) T-cell-reconstituted Rag1-deficient DIO mice, suggesting its beneficial effect on insulin resistance is T-cell-dependent. Therefore, regulatory ODNR01 reduces obesity-associated insulin resistance through modulation of T-cell differentiation.


PROVIDER: S-EPMC3491840 | BioStudies | 2012-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3441148 | BioStudies
2009-01-01 | S-EPMC3063199 | BioStudies
2015-01-01 | S-EPMC4323023 | BioStudies
2017-01-01 | S-EPMC5485658 | BioStudies
2020-01-01 | S-EPMC7461801 | BioStudies
1000-01-01 | S-EPMC5958108 | BioStudies
2017-06-27 | MODEL1606020000 | BioModels
1000-01-01 | S-EPMC3089774 | BioStudies
2015-01-01 | S-EPMC4717188 | BioStudies
2010-01-01 | S-EPMC2880832 | BioStudies